A case of myelodysplastic syndrome/myeloproliferative neoplasm (MDS/MPN) successfully treated with lenalidomide

Lenalidomide is an immunomodulatory drug which is used to treat patients with MDS with deletion 5q chromosomal abnormality. In 2008, WHO introduced a new disease entity called MDS/MPN. No specific treatment for MDS/MPN subtype has yet been identified. We report a patient with MDS/MPN who responded w...

Descripción completa

Detalles Bibliográficos
Autor principal: Islam, Anwarul
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Ltd 2015
Materias:
Case Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4527794/
https://www.ncbi.nlm.nih.gov/pubmed/26273440
http://dx.doi.org/10.1002/ccr3.293
_version_ 1782384619322081280
author Islam, Anwarul
author_facet Islam, Anwarul
author_sort Islam, Anwarul
collection PubMed
description Lenalidomide is an immunomodulatory drug which is used to treat patients with MDS with deletion 5q chromosomal abnormality. In 2008, WHO introduced a new disease entity called MDS/MPN. No specific treatment for MDS/MPN subtype has yet been identified. We report a patient with MDS/MPN who responded well to lenalidomide therapy.
format Online
Article
Text
id pubmed-4527794
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher John Wiley & Sons, Ltd
record_format MEDLINE/PubMed
spelling pubmed-45277942015-08-13 A case of myelodysplastic syndrome/myeloproliferative neoplasm (MDS/MPN) successfully treated with lenalidomide Islam, Anwarul Clin Case Rep Case Reports Lenalidomide is an immunomodulatory drug which is used to treat patients with MDS with deletion 5q chromosomal abnormality. In 2008, WHO introduced a new disease entity called MDS/MPN. No specific treatment for MDS/MPN subtype has yet been identified. We report a patient with MDS/MPN who responded well to lenalidomide therapy. John Wiley & Sons, Ltd 2015-07 2015-05-15 /pmc/articles/PMC4527794/ /pubmed/26273440 http://dx.doi.org/10.1002/ccr3.293 Text en © 2015 The Author. Clinical Case Reports published by John Wiley & Sons Ltd. http://creativecommons.org/licenses/by-nc/4.0/ This is an open access article under the terms of the Creative Commons Attribution-NonCommercial License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.
spellingShingle Case Reports
Islam, Anwarul
A case of myelodysplastic syndrome/myeloproliferative neoplasm (MDS/MPN) successfully treated with lenalidomide
title A case of myelodysplastic syndrome/myeloproliferative neoplasm (MDS/MPN) successfully treated with lenalidomide
title_full A case of myelodysplastic syndrome/myeloproliferative neoplasm (MDS/MPN) successfully treated with lenalidomide
title_fullStr A case of myelodysplastic syndrome/myeloproliferative neoplasm (MDS/MPN) successfully treated with lenalidomide
title_full_unstemmed A case of myelodysplastic syndrome/myeloproliferative neoplasm (MDS/MPN) successfully treated with lenalidomide
title_short A case of myelodysplastic syndrome/myeloproliferative neoplasm (MDS/MPN) successfully treated with lenalidomide
title_sort case of myelodysplastic syndrome/myeloproliferative neoplasm (mds/mpn) successfully treated with lenalidomide
topic Case Reports
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4527794/
https://www.ncbi.nlm.nih.gov/pubmed/26273440
http://dx.doi.org/10.1002/ccr3.293
work_keys_str_mv AT islamanwarul acaseofmyelodysplasticsyndromemyeloproliferativeneoplasmmdsmpnsuccessfullytreatedwithlenalidomide
AT islamanwarul caseofmyelodysplasticsyndromemyeloproliferativeneoplasmmdsmpnsuccessfullytreatedwithlenalidomide

Ejemplares similares